Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib

(2018) Synthesis and cytotoxic evaluation of some novel diarylamide possessing quinoxalinedione based on sorafenib. Research in Pharmaceutical Sciences. pp. 168-176. ISSN 17355362 (ISSN)

Full text not available from this repository.

Abstract

A series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-Aminophenol was first protected which then followed by O-Arylation with 5-chloro-2-nitroaniline to provide compound d. Reduction of the nitro group of compound d and cyclization of the diamine group of compound e with oxalic acid afforded compound f which on deacetylation yeilded compound g. Then compound g was reacted with different acyl halides to afford the target compounds 1h-1p. Chemical structures of synthesized compounds were confirmed by 1H NMR and FT-IR analysis. All compounds were evaluated at 1, 10, 50 and 100 μM concentrations for their cytotoxicity against HeLa and MCF-7 cancer cell lines. Some of the compounds showed good cytotoxic activity, especially compounds 1i and 1k-1n with the IC50 values of 19, 16, 22, 18, and 16 μM against MCF-7 cell line and 20, 18, 25, 20, and 18 μM against HeLa cell line, respectively. © 2018 Medknow Publications. All rights reserved.

Item Type: Article
Keywords: Amide Cytotoxicity Quinoxalinedione Sorafenib 2,5 dichloro n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenylbenzamide 4 (tert butyl) n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenylbenzamide 4 aminophenol 4 chloro n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenylbenzamide acid halide aniline derivative diamine diarylamide doxorubicin heterocyclic compound n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxy2 methylphenylbenzamide n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenyl 3 (trifluoromethyl)benzamide n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenyl 3,5 dinitrobenzamide n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenyl 4 (trifluoromethyl)benzamide n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenyl 4 nitrobenzamide n 4 2,3 dioxo 1,2,3,4 tetrahydroquinoxalin 6 yloxyphenyl4 fluoro 3 (trifluoromethyl)benzamide nitro derivative oxalic acid quinoxalindione sorafenib derivative unclassified drug Article arylation concentration response controlled study cyclization deacetylation drug cytotoxicity drug synthesis HeLa cell line human human cell IC50 infrared spectroscopy MCF-7 cell line proton nuclear magnetic resonance reduction (chemistry) structure analysis
Divisions: Faculty of Pharmacy and Pharmaceutical Sciences > گروه شیمی دارویی
Page Range: pp. 168-176
Journal or Publication Title: Research in Pharmaceutical Sciences
Journal Index: Scopus
Volume: 13
Number: 2
Identification Number: https://doi.org/10.4103/1735-5362.223802
ISSN: 17355362 (ISSN)
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/9901

Actions (login required)

View Item View Item